Cargando…

Value of routine blood tests for prediction of mortality risk in hip fracture patients

BACKGROUND: There is a 5- to 8-fold increased risk of mortality during the first 3 months after a hip fracture. Several risk factors are known. We studied the predictive value (for mortality) of routine blood tests taken on admission. METHODS: 792 hip fracture patients were included prospectively; b...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosfeldt, Mathias, Pedersen, Ole B, Riis, Troels, Worm, Henning O, van Mark, Susanne, Jørgensen, Henrik L, Duus, Benn R, Lauritzen, Jes B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278654/
https://www.ncbi.nlm.nih.gov/pubmed/22248167
http://dx.doi.org/10.3109/17453674.2011.652883
_version_ 1782223600352231424
author Mosfeldt, Mathias
Pedersen, Ole B
Riis, Troels
Worm, Henning O
van Mark, Susanne
Jørgensen, Henrik L
Duus, Benn R
Lauritzen, Jes B
author_facet Mosfeldt, Mathias
Pedersen, Ole B
Riis, Troels
Worm, Henning O
van Mark, Susanne
Jørgensen, Henrik L
Duus, Benn R
Lauritzen, Jes B
author_sort Mosfeldt, Mathias
collection PubMed
description BACKGROUND: There is a 5- to 8-fold increased risk of mortality during the first 3 months after a hip fracture. Several risk factors are known. We studied the predictive value (for mortality) of routine blood tests taken on admission. METHODS: 792 hip fracture patients were included prospectively; blood tests were taken on admission. Follow-up data on mortality were obtained from the civil registration system. Patients were divided into 2 groups based on whether they had survived at least 90 days after the hip fracture. To estimate which laboratory tests could be used to predict outcome, we used receiver operation characteristic (ROC) curves. RESULTS: 3-month mortality could be predicted with 69% accuracy from the level of plasma creatinine in standard admission blood tests. The mortality in patients with elevated levels of creatinine was almost 3-fold that of the patients with normal creatinine. Mortality was also associated with age, low blood hemoglobin, high plasma potassium, and low plasma albumin levels. INTERPRETATION: Our findings could be of use in identifying patients who might benefit from increased attention perioperatively.
format Online
Article
Text
id pubmed-3278654
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Informa Healthcare
record_format MEDLINE/PubMed
spelling pubmed-32786542012-02-15 Value of routine blood tests for prediction of mortality risk in hip fracture patients Mosfeldt, Mathias Pedersen, Ole B Riis, Troels Worm, Henning O van Mark, Susanne Jørgensen, Henrik L Duus, Benn R Lauritzen, Jes B Acta Orthop Article BACKGROUND: There is a 5- to 8-fold increased risk of mortality during the first 3 months after a hip fracture. Several risk factors are known. We studied the predictive value (for mortality) of routine blood tests taken on admission. METHODS: 792 hip fracture patients were included prospectively; blood tests were taken on admission. Follow-up data on mortality were obtained from the civil registration system. Patients were divided into 2 groups based on whether they had survived at least 90 days after the hip fracture. To estimate which laboratory tests could be used to predict outcome, we used receiver operation characteristic (ROC) curves. RESULTS: 3-month mortality could be predicted with 69% accuracy from the level of plasma creatinine in standard admission blood tests. The mortality in patients with elevated levels of creatinine was almost 3-fold that of the patients with normal creatinine. Mortality was also associated with age, low blood hemoglobin, high plasma potassium, and low plasma albumin levels. INTERPRETATION: Our findings could be of use in identifying patients who might benefit from increased attention perioperatively. Informa Healthcare 2012-02 2012-02-08 /pmc/articles/PMC3278654/ /pubmed/22248167 http://dx.doi.org/10.3109/17453674.2011.652883 Text en Copyright: © Nordic Orthopaedic Federation http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited.
spellingShingle Article
Mosfeldt, Mathias
Pedersen, Ole B
Riis, Troels
Worm, Henning O
van Mark, Susanne
Jørgensen, Henrik L
Duus, Benn R
Lauritzen, Jes B
Value of routine blood tests for prediction of mortality risk in hip fracture patients
title Value of routine blood tests for prediction of mortality risk in hip fracture patients
title_full Value of routine blood tests for prediction of mortality risk in hip fracture patients
title_fullStr Value of routine blood tests for prediction of mortality risk in hip fracture patients
title_full_unstemmed Value of routine blood tests for prediction of mortality risk in hip fracture patients
title_short Value of routine blood tests for prediction of mortality risk in hip fracture patients
title_sort value of routine blood tests for prediction of mortality risk in hip fracture patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278654/
https://www.ncbi.nlm.nih.gov/pubmed/22248167
http://dx.doi.org/10.3109/17453674.2011.652883
work_keys_str_mv AT mosfeldtmathias valueofroutinebloodtestsforpredictionofmortalityriskinhipfracturepatients
AT pedersenoleb valueofroutinebloodtestsforpredictionofmortalityriskinhipfracturepatients
AT riistroels valueofroutinebloodtestsforpredictionofmortalityriskinhipfracturepatients
AT wormhenningo valueofroutinebloodtestsforpredictionofmortalityriskinhipfracturepatients
AT vanmarksusanne valueofroutinebloodtestsforpredictionofmortalityriskinhipfracturepatients
AT jørgensenhenrikl valueofroutinebloodtestsforpredictionofmortalityriskinhipfracturepatients
AT duusbennr valueofroutinebloodtestsforpredictionofmortalityriskinhipfracturepatients
AT lauritzenjesb valueofroutinebloodtestsforpredictionofmortalityriskinhipfracturepatients